Osteoarthritis: Largest genome-wide association study uncovers drug targets and therapy opportunities

Osteoarthritis is the leading cause of disability and chronic pain worldwide, affecting an estimated 595 million people globally. Projections suggest that this number will rise to 1 billion by 2050. Despite its profound impact on individuals and societies, no disease-modifying treatments are currently available.

See also  From inflammation to fibrosis: Research explores cellular changes as COVID-19 lung damage worsens
Total
0
Share
Need Help?